tiprankstipranks
Trending News
More News >
IRLAB Therapeutics AB Class A (SE:IRLAB.A)
:IRLAB.A
Sweden Market

IRLAB Therapeutics AB Class A (IRLAB.A) Ownership - Who Owns IRLAB Therapeutics AB Class A?

Compare
0 Followers

IRLAB Therapeutics AB Class A (IRLAB.A) Ownership Overview

<0.01%99.99%
<0.01% ETFs
99.99% Public Companies and
Individual Investors
The ownership structure of IRLAB Therapeutics AB Class A (SE:IRLAB.A) stock is a mix of institutional, retail, and individual investors. , and 99.99% is owned by Public Companies and Individual Investors.
The ownership structure of IRLAB Therapeutics AB Class A (SE:IRLAB.A) stock is a mix of institutional, retail, and individual investors. , <0.01% is owned by Insiders

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,135Institution<0.01%2,267

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,135Institution<0.01%2,206

FAQ

Who Owns IRLAB Therapeutics AB Class A (SE:IRLAB.A)?
Currently, no data Available
What percentage of IRLAB Therapeutics AB Class A (SE:IRLAB.A) stock is held by institutional investors?
Currently, no data Available
What percentage of IRLAB Therapeutics AB Class A (SE:IRLAB.A) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.99% of IRLAB Therapeutics AB Class A (SE:IRLAB.A) stock is held by retail investors.
    Who owns the most shares of IRLAB Therapeutics AB Class A (SE:IRLAB.A)?
    SPDR owns the most shares of IRLAB Therapeutics AB Class A (SE:IRLAB.A).
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis